Nov 11, 2021 / 03:30PM GMT
Tiago Felipe Fauth - Crédit Suisse AG - Research Division - Research Analyst
All right. Welcome, everyone, to Credit Suisse's 30th Annual Healthcare Conference. I'm Tiago Fauth. I'm a biotech analyst here at Credit Suisse, and we're joined today by AbCellera. We have Carl Hansen, CEO, for a fireside chat. Happy to ask any questions on your behalf and try to work those in, in our fireside chat. The e-mail is T-I-A-G-O dot F-A-U-T-H @ credit-suisse. Happy to try to address some those.
Questions and Answers:
Tiago Felipe Fauth - Crédit Suisse AG - Research Division - Research AnalystBut Carl, as usual, we generally like to start with a brief overview, and you just reported earnings fairly recently with some fairly impressive results from an operations perspective. Can you just kind of briefly recap the AbCellera story and the progress you've made since you've gone public almost a year ago now, right? That's -- it feels like it's only yesterday so...
Carl L.G. Hansen -